Fungal infections in the organ transplant recipient

Current Opinion in Organ Transplantation

Volumn 6, Issue 4, 2001, Pages 284-289

  Avery, Robin K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; CYCLOSPORIN; ECHINOCANDIN; FLUCONAZOLE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MONOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; LIPID; NYSTATIN; PLACEBO; POSACONAZOLE; PYRROLE DERIVATIVE; RAVUCONAZOLE; UNCLASSIFIED DRUG; VORICONAZOLE;

ANTIBIOTIC RESISTANCE; ASPERGILLOSIS; ASPERGILLUS; BRONCHOSCOPY; CANDIDA; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS; DRUG ABSORPTION; DRUG FORMULATION; DRUG RESEARCH; EARLY DIAGNOSIS; ENVIRONMENTAL FACTOR; FOOD DRUG INTERACTION; FUSARIUM; GRAFT INFECTION; HUMAN; HYPOGAMMAGLOBULINEMIA; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTENSIVE CARE UNIT; LIVER TOXICITY; MYCOSIS; NEPHROTOXICITY; NONHUMAN; OPEN LUNG BIOPSY; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PREVALENCE; PROPHYLAXIS; RECIPIENT; REVIEW; RISK FACTOR; THROMBOCYTOPENIA; YEAST;

EID: 0035683883     PISSN: 10872418     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075200-200112000-00002     Document Type: Review

References (84)

1. Fungal infections in solid organ transplant tecipients
2. Fungal infections in solid-organ tranplantation
3. Infections in solid-organ transplant recipients
4. Prevention of fungal and hepatitis virus infections in liver transplantation
5. Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent
6. Clinical aspects of fungal infection in organ transplant recipients
7. Fungal complications of transplantation: Diagnosis, treatment and prevention
8. Epidemiology of fungal infections in solid organ transplant patients
9. Fungal infections in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature
10. Fungal infections in liver transplant recipients
11. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: A multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients
12. Practice guidelines for the treatment of fungal infections. For the Mycoses Study Group. Infectious Diseases Society of America
13. Introduction to antifungal drugs
14. Practice guidelines for the treatment of candidiasis. Infectious Disease Society of America
15. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America
16. Infection in the organ transplant recipient
17. Infection in organ-transplant recipients
18. Fatal aspergillosis associated with smoking contaminated marijuana, in a marrow transplant recipient
19. Invasive aspergillosis
20. Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients
21. Infections after liver transplantation. An analysis of 101 consecutive cases
22. Infections due to dematiaceous fungi in organ transplant recipients: Case report and review
23. Aspergillus and lung transplantation
24. Aspergillosis in lung transplantation: Incidence, risk factors, and prophylactic strategies
25. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression
26. Association of fungal infection nd increased mortality in liver transplant recipients
27. Intra-abdominal fungal infections after pancreatic transplantation: Incidence, treatment, and outcome
28. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients
29. The indirect effects of cytomegalovirus infection on the outcome of organ transplantation
30. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland
31. Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients
32. Spectrum of Aspergillus infection in lung transplant recipients: Case series and review of the literature
33. Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation
34. Invasive aspergillosis in liver transplant recipients in the 1990s
35. Aspergillus airway colonization and invasive disease after lung transplantation
36. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients
37. Topical amphotericin B application in severe bronchial aspergillosis after lung transplantation: Report of experiences in 3 cases
38. Anastomotic infections in lung transplant recipients
39. Pre-emptive therapy with azoles in lung transplant patients. Geneva Lung Transplantation Group
40. Aspergillus and endobronchial abnormalities in lung transplant recipients
41. Thrombocytopenia in liver transplant recipients: Predictors, impact on fungal infections, and role of endogenous thrombopoietin
42. Hypogammaglobulinemia in lung transplant recipients
43. Approaches to fungal diagnosis in transplantation
44. Open lung biopsy provides a higher and more specific diagnostic yield compared with broncho-alveolar lavage in immunocompromised patients. Fungal Study Group
45. Microbiologic diagnosis of invasive fungal infections in transplant recipients
46. Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study
47. Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients
48. Aspergillus antigenuria compared with antigenemia in bone marrow transplant recipients
49. Guidelines for the investigation of invasive fungal infections in hematological malignancy and solid organ transplantation. British Society for Med Mycol
50. Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: Implications for the management of febrile neutropenia
51. Panfungal PCR assay for detection of fungal infection in human blood specimens
52. Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation
53. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial
54. Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy
55. Targeted prophylaxis with amphotericin B lipid complex in liver transplantation
56. Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study
57. Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis
58. Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis
59. Antifungal prophylaxis during the early postoperative period of lung transplantation. Velencia Lung Transplant Group
60. Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients
61. Infection after lung transplantation
62. Epidemiology and management of infections after lung transplantation
63. Enhanced cyclosporine-itraconazole interaction with cola in lung transplant recipients
64. Emerging fungal pathogens: Evolving challenges to immunocompromised patients for the twenty-first century
65. Fusarium infection after solid-organ transplantation
66. Phaeohyphomycosis due to Scopulariopsis brumptii in a liver transplant recipient
67. Paecilomyces variotii in a pediatric patient with lung transplantation
68. Fatal case of Trichoderma harzianum infection in a renal transplant recipient
69. Invasive Scedosporium apiospermum infection in a heart transplant recipient presenting with multiple skin nodules and a pulmonary consolidation
70. Scedosporium apiospermum (Pseudallescheria boydii) infection in a heart transplant recipient: A case of mistaken identity
71. The epidemiology of pseudallescheriasis complicating transplantation: Nosocomial and community-acquired infection
72. Disseminated Dactylaria constricta infection in a renal transplant recipient
73. Invasive gastrointestinal zygomycosis in a liver transplant recipient: Case report and review of zygomycosis in solid-organ transplant recipients
74. Soft-tissue fungal infections: Surgical management of 12 immunocompromised patients
75. The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplant Team
76. Candida (Torulopsis) glabrata septic arthritis
77. Amphotericin B and its new formulations: Pharmacologic characteristics, clinical efficacy, and tolerability
78. Amphotericin B preparations: A maximum tolerated dose in severe invasive fungal infections?
79. New targets and delivery systems for antifungal therapy
80. In vitro activities of four novel triazoles against Scedosporium spp.
81. Antigen detection in the diagnosis and management of a patient with probable cerebral aspergillosis treated with voriconazole
82. Update on antifungals targeted to the cell wall: Focus on beta-1,3-glucan synthase inhibitors
83. Granulocyte colony-stimulating factor administered in vivo augments neutrophil-mediated activity against oppportunistic fungal pathogens
84. Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens